The "soil of the human body" and the extrahuman life it supports are an underappreciated player when it comes to developing immunotherapies and other precision medicine approaches, Vince Young, a professor at the University of Michigan Medical School, said in his keynote address at Monday's FDA workshop on the science and regulation of live microbiome-based products to treat disease.